Wednesday, May 18, 2016 11:36:53 AM
NASDAQ: I don't think Dr. Wolgen will take us to Nasdaq any day soon.
There is an added value of being on the ASX in a time where
we would be easy prey for shorters and other manipulators. This is not happening to the same extent on the ASX. I am also involved in other pharma companies here in the US and especially one of them, CT$X is getting killed by all sorts of manipulation. It's sad to watch. Clinuvel's succes is reliant on steady growth, trustworthy management and time. Right now we have it all but going to Nasdaq before the company has some fat on its bones would not be beneficial IMO. Also, I personally believe that stocks are in for a dramatic decline. When that happens, it will be good to be a small unknown, undervalued company sheltered on the ASX.
Give it time my friend. In a volatile World with crazy P/E ratios and bloated stock prices it's good to be one of the few companies that actually executes quietly.
FEATURED North Bay Resources Announces Mt. Vernon Gold Mine Startup, Sierra County, California • Aug 5, 2024 9:00 AM
Fifty 1 Labs, Inc. and All-In-Extracts Announce Joint Venture to Develop and Release New Testosterone Boosting Supplement • BLEG • Aug 5, 2024 8:30 AM
Kona Gold Beverages, Inc. Announces Strategic Initiatives and Corporate Direction Changes • KGKG • Aug 2, 2024 2:00 PM
POET and Luxshare Tech Expand Product Offerings for Artificial Intelligence Networks • POET • Aug 1, 2024 9:28 AM
Management Discusses Financial Filings of Global Arena Holding Inc., for 10-K 2023 and 10-Q, 1st Quarter 2024 • GAHC • Aug 1, 2024 9:14 AM
VAYK Announces LOI to Acquire $1 Million Home Service Company to Support Airbnb Business • VAYK • Aug 1, 2024 9:00 AM